Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Biotechnologies · Taiwan · 2023-01-26

Processing Time
76 days
Decision Date
2023-01-26
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize microscopy and novel machine-learning models in the cryopreservation of therapeutic cells. This work aims to improve life-saving cell-based medicinal products and facilitate the implementation of cell-based therapies for diseases such as cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research facilitates the implementation of cell-based therapies for a wide range of diseases, including blood cancers, which is of great importance to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 73 citations and 7 first-authored peer-reviewed journal articles demonstrate a major influence on other scholars in the field.

3 Balance of Factors Met

The petitioner's expertise in microscopy and machine-learning for cell preservation provides a unique benefit that justifies waiving the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in mechanical engineering and a strong publication record including 7 first-authored journal articles and 73 citations. Evidence also included 2 completed peer reviews for an authoritative journal and 4 expert recommendation letters confirming the national importance of his research in the cell therapy industry.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions
Reference Letters Independent

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.
View Case

Others

Healthcare · Bosnia and Herzegovina

WeGreened EB-2 (NIW) approved
District of Columbia 591 days 2022-04-22
The petitioner proposes to utilize immunological and molecular biology techniques to develop inclusive and effective T-cell therapies. Her work focuses on improving outcomes for patients suffering from high-risk solid tumor cancer, hematologic malignancies, and post-transplant viral infections, specifically treating complications from hematopoietic stem cell transplantations.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 51 days 2025-09-25
The petitioner proposes to develop, engineer, and refine scalable stem-cell and progenitor-cell-derived organoid systems to revolutionize human organ modeling. Her work focuses on creating miniature, lab-grown structures that replicate complex human tissues for use in drug screening, disease modeling, and patient-specific regenerative therapies.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2025-02-18
The petitioner proposes to utilize single-cell multi-omic analysis and high-throughput microscopy to identify molecular and systems-level processes driving carcinogenesis and immune responses. This work aims to uncover mechanisms governing cellular decision-making to enable more precise and effective cancer treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 76 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist